Michael Goettler Resigns from Bausch Health's Board of Directors

Rhea-AI Summary

Bausch Health (NYSE:BHC) announced that Michael Goettler resigned from its Board of Directors, effective June 30, 2026, following his appointment as President and CEO of Knoa Pharma.

Bausch Health stated that his resignation was not due to any disagreement regarding its operations, policies or practices.

News Market Reaction – BHC

+2.73%

+2.73% Session close to close

In the Jul 2 session, BHC gained 2.73%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LAVAL, QC, July 1, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.

"We thank Michael for his valued service and wish him the best in his new role," said John A. Paulson, Chairperson of the Bausch Health Board of Directors.

Mr. Goettler's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn. 

Investor Contact:	Media Contact:
Garen Sarafin	Katie Savastano
ir@bauschhealth.com	corporate.communications@bauschhealth.com
(877) 281-6642 (toll free)	(908) 569-3692
BHC-ORGANIZATION

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/michael-goettler-resigns-from-bausch-healths-board-of-directors-302816240.html

SOURCE Bausch Health Companies Inc.

FAQ

Why did Michael Goettler resign from Bausch Health's (NYSE:BHC) Board of Directors in June 2026?

Michael Goettler resigned from Bausch Health’s Board in connection with his appointment as President and CEO of Knoa Pharma. According to Bausch Health, the resignation was not related to any disagreement over company operations, policies or practices.

When was Michael Goettler's resignation from Bausch Health's Board effective?

Michael Goettler’s resignation from Bausch Health’s Board of Directors was effective June 30, 2026. According to Bausch Health, the announcement of his departure was made on July 1, 2026, following his appointment at Knoa Pharma as President and Chief Executive Officer.

Did Michael Goettler leave Bausch Health (BHC) due to disagreements with the company?

Bausch Health stated that Michael Goettler’s resignation was not the result of any disagreement with the company. According to Bausch Health, this includes no disputes regarding its operations, policies or practices during his tenure on the Board of Directors.

What new role did former Bausch Health director Michael Goettler take after resigning?

After resigning from Bausch Health’s Board, Michael Goettler became President and Chief Executive Officer of Knoa Pharma. According to Bausch Health, his Board resignation was directly connected to this leadership appointment at Knoa Pharma, effective around June 30, 2026.

How did Bausch Health respond to Michael Goettler's June 2026 Board resignation?

Bausch Health thanked Michael Goettler for his valued service and wished him success in his new role. According to Bausch Health, Chairperson John A. Paulson expressed appreciation on behalf of the Board following Goettler’s resignation effective June 30, 2026.